Post by Johnson & Johnson Innovative Medicine UK

We’re pleased to be attending the annual British Society of Gastroenterology (BSG) meeting this week, joining colleagues and partners in Liverpool as the community focuses on ‘Transforming Care Through Precision & Personalised Medicine’. Through expert-led education and meaningful exchange throughout the meeting, we look forward to exploring the evolving challenges shaping inflammatory bowel disease (IBD) care today, as we work towards the shared ambition of delivering more personalised care and meaningful progress for people living with IBD. Johnson & Johnson is proud to be a sponsoring partner of this year’s meeting. With over half a million people in the UK living with IBD, there is a clear and growing need to enable earlier intervention, improve patient pathways, and deliver more sustainable care for patients, the NHS and wider society. #Immunology #IBD CP-588514 | June 2026